Clinical trial
Relapsed/Refractory Follicular Lymphoma - Rituximab Therapy in Combination With Chemotherapy
NCT02472756 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relapsed/Refractory Follicular Lymphoma - Rituximab Therapy in Combination With Chemotherapy
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 19, 2008
- Completion date
- May 30, 2014
- Enrollment
- 41 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.